Skip to main content

Publisher: Wiley-Blackwell

Volume 9, Number 2, August 2006

Favourites:
ADD

Infliximab (Remicade®): from bench to clinical practice. A paradigm shift in rheumatology practice
pp. 107-118(12)
Authors: HSIA, Elizabeth C.; RULEY, Kristin M.; RAHMAN, Mahboob U.

Favourites:
ADD
Favourites:
ADD

Infliximab versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a preliminary study from China
pp. 127-130(4)
Authors: BAO, Chun-De; ZHANG, Feng-Chun; HOU, Yong; HUANG, Feng; WU, Dong-Hai; NI, Li-Qing; YAO, Chen

Favourites:
ADD
Favourites:
ADD

The efficacy of infliximab for patients with rheumatoid arthritis in Japan: results of 5000 cases by post-marketing surveillance data
pp. 142-145(4)
Authors: OKA, Hiroshi; NISHIOKA, Kusuki; TOGO, Masanori; OCHI, Takahiro

Favourites:
ADD

Clinical experience with tumor necrosis factor blockers in Korean rheumatoid arthritis patients
pp. 146-149(4)
Authors: HUR, Jin-Wuk; CHOI, Chan-Bum; BAE, Sang-Cheol

Favourites:
ADD

Clinical experience with infliximab among Filipino patients with rheumatic diseases
pp. 150-156(7)
Authors: NAVARRA, Sandra V.; RASO, Anne-Annette; LICHAUCO, Juan Javier; TAN, Perry P.

Favourites:
ADD

The use of anti-tumour necrosis factor-α therapies for rheumatoid arthritis in Singapore
pp. 157-160(4)
Authors: THONG, B. Y. H.; VASOO, S.; KOH, E. T.

Favourites:
ADD

Experience of antitumor necrosis factor-α therapies in Taiwan
pp. 161-164(4)
Authors: James Cheng-Chung, WEI; Joung-Liang, LAN; Der-Yuan, CHEN; Chung-Tei, CHOU; Ming-Chih, CHOU; Gregory, J. TSAY

Favourites:
ADD

Adverse effects of tumour necrosis factor-α blocking agents
pp. 165-169(5)
Authors: PARK, Kyung-Su; PARK, Sung-Hwan

Favourites:
ADD

Risk of tuberculosis in a Chinese registry of rheumatoid arthritis and ankylosing spondylitis for tumour necrosis factor-α antagonists
pp. 170-174(5)
Authors: HUANG, Feng; WANG, Lisha; ZHANG, Jianglin; DENG, Xiaohu; GUO, Junhua; ZHANG, Yamei

Favourites:
ADD

Guidelines for tuberculosis prophylaxis during anti-tumour necrosis factor-α treatment: Indian Rheumatology Association
pp. 181-183(3)
Authors: HANDA, R.; MISRA, R.; CHATURVEDI, V. P.; PISPATI, P. K.; RAO, U. R. K.; JOSHI, V. R.

Favourites:
ADD

Philippine guidelines on the screening for tuberculosis prior to the use of biologic agents
pp. 184-192(9)
Authors: LICHAUCO, Juan Javier T.; TANKEH-TORRES, Sandra A.; NAVARRA, Sandra V.; DANS for the Task Force for TB Screening Prior to Use of Biologic Agents, Leonila F.

Favourites:
ADD

Extended indications for anti-tumor necrosis factor-α therapy
pp. 193-199(7)
Authors: YOON, Chong-Hyeon; KIM, Ho-Youn

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more